AYNUR SÜNER, İLKAY KARAOĞLAN, AYŞE ÖZLEM METE, MUSTAFA NAMIDURU, VUSLAT BOŞNAK, İBRAHİM BAYDAR

Assessment of bloodstream infections and risk factors in an intensive care unit

Background/aim: Nosocomial bloodstream infection (BSI) increases mortality rates, duration of stay in hospital, and treatment costs. This study was conducted to determine the rate and the risk factors of BSIs among intensive care unit patients. Materials and methods: Sixty-four patients with BSIs (patient group) and 79 patients without a nosocomial infection (control group) were enrolled in the study. Centers for Disease Control and Prevention criteria were used for diagnosing BSIs. Potential risk factors were evaluated by multivariate logistic regression model. Results: The BSI development rate was 15.7% (64/407), with an incidence rate of 18.2/1000 patient days. Distribution of pathogens among BSI patients were as follows: gram-positive cocci, 42.18% (27/64); gram-negative cocci, 34.3% (22/64); and Candida spp., 23.4% (15/64). Risk factors were determined as intubation, arterial catheter, tracheostomy, duration of intubation, duration of catheter use, duration of nasogastric catheter, underlying diseases of chronic renal failure and diabetes mellitus, implemented treatments of sedation and enteral nutrition, and APACHE II score. Conclusion: BSIs are the leading cause of mortality and morbidity in intensive care unit patients. Determination of the local risk factors is important and necessary for decreasing the rate of BSIs and the mortality rates.

Anahtar Kelimeler:

Bloodstream infection, candidemia, intensive care unit

Assessment of bloodstream infections and risk factors in an intensive care unit

Keywords:

Bloodstream infection, candidemia, intensive care unit,

PDF

___

Eggimann P, Pittet D. Infection control in the ICU. Chest 2001; 120: 2059–2093.
Gündeş S, Baykara N, Özdamar D, Bozkurt N, Wilke A, Toker K. Bir yoğun bakım ünitesinde nozokomial infeksiyonlar. Hastane İnfeksiyonları Derg 2003; 7: 149–152 (article in Turkish).
Şardan Çetinkaya Y. Metisilin dirençli Staphylococcus aureus infeksiyonlarının epidemyolojisi ve kontrolü. Hastane İnfeksiyonları Derg 2000; 4: 205–217 (article in Turkish).
Warren DK, Zack JE, Elward AM, Cox MJ, Fraser VJ. Nosocomial primary bloodstream infections in intensive care unit patients in a nonteaching community medical center: a 21- month prospective study. Clin Infect Dis 2001; 33: 1329– 1335.
Apostolopoulou E, Katsaris G, Katostaras T. Risk factors for nosocomial bloodstream infections. Br J Nurs 2003; 12: 718– 726.
Esen S, Leblebicioglu H. Prevalence of nosocomial infections at intensive care units in Turkey: a multicentre 1-day point prevalence study. Scand J Infect Dis 2004; 36: 144–148.
Meriç M, Willke A, Çağlayan Ç, Toker K. Intensive care unit- acquired infections: incidence, risk factors and associated mortality in a Turkish university hospital. Jpn J Infect Dis 2005; 58: 297–302.
Aygen B, Kayabaş Ü, Güven M, Doganay M, Sümerkan B, Yıldız O. Erciyes Üniversitesi Tıp Fakültesi Yoğun Bakım Üniteleri nozokomiyal infeksiyonları sürveyansı: epidemiyoloji, risk faktörleri ve prognozu etkileyen faktörler. Yoğun Bakım Dergisi 2001; 1: 122–130 (article in Turkish).
De Leon-Rosellas SP, Molinar-Ramos F, Dominguez Cherit G, Rangel Frausto MS, Vazquez Ramos VG. Prevalence of infections intensive care units in Mexico: a multicenter study. Crit Care Med 2000; 28: 1316–1321.
Erbay H, Yalcin AN, Serin S, Turgut H, Tomatir E, Cetin B, Zencir M. Nosocomial infection in intensive care unit in a Turkish university hospital: a 2 year survey. Intensive Care Med 2003; 29: 1482–1488.
Aktaş F. Yoğun bakım infeksiyonlarında patogenez. In: Köksal İ, Çakar N, Arman D, editors. Yoğun Bakım İnfeksiyonları. Ankara, Turkey: Bilimsel Tıp Yayınevi; 2005. pp. 67–75 (book chapter in Turkish).
Pittet D, Li N, Woolson RF, Wenzel RP. Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model. Clin Infect Dis 1997; 24: 1068–1078.
Shorr AF, Kelly KM, Kollef MH. Transfusion: a risk factor for nosocomial bacteremia in the intensive care unit. Chest 2004; 126: 763.
Peters M, Petros A, Dixon G, Inwald D, Klein N. Acquired immunoparalysis in pediatric intensive care; prospective observational study. BMJ 1999; 319: 609–610.
Erdem B. Hastane infeksiyonlarına yol açan bakteriler. In: Ustaçelebi Ş, editor. Temel ve Klinik Mikrobiyoloji. Ankara, Turkey: Güneş Kitabevi; 1999. pp. 734–735 (book chapter in Turkish).
Agarwal R, Gupta D, Ray P, Aggarwal AN, Jindal SK. Epidemiology, risk factors and outcome of nosocomial infections in a respiratory intensive care unit in North India. J Infect 2006; 53: 98–105.
Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systemic review and meta-analysis. Clin Infect Dis 2004; 39: 206–217.
National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32: 470–485.
Rangel-Frausto MS, Wiblin T, Blumberg HM, Siman L, Patterson J, Rinaldi M, Pfalger M, Edwards JE Jr, Jarvis W, Dawson J et al. National Epidemiology of Mycoses Survey (NEMIS): Variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 1999; 29: 253–258.
Hope W, Morton A, Eisen DP. Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use. J Hosp Infect 2002; 50: 56–65.
Snydman DR: Shifting patterns in the epidemiology of nosocomial Candida infections. Chest 2003; 123: 500–503.
Barberino MG, Silva N, Rebouças C, Barreiro K, Alcãntra AP, Netto EM, Albuquerque L, Brites C. Evaluation of blood stream infections by Candida in three tertiary hospitals in Salvador, Brazil: a case-control study. Braz J Infect Dis 2006; 10: 36–40.
Glöckner A, Wiersbitzky M, Schulz K, Bernhardt H. Risk factors for systemic fungal infection in patients of non- surgical ICU. In: Abstracts of the 5th Congress of the European Confederation of Medical Mycology, 3–6 June 1999, Dresden, Germany, 1999; 42: 177.
Blumberg HM, Jarvis WR, Soucie JM, Edwards JE, Patterson JE, Pfaller MA. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. Clin Infect Dis 2001; 33: 177–186.
Cheng MF, Yang YL, Yao TJ, Lin CY, Liu JS, Tang RB, Yu KW, Fan YH, Hsieh KS, Ho M et al. Risk factor for fatal candidemia caused by Candida albicans and non-albicans Candida species. BMC Infect Dis 2005; 5: 22.
Yenigün Koçak B, Kuloğlu F, Doğan Çelik A, Akata F. Bir üçüncü basamak hastenesinde erişkin kandidemi olgularının epidemiyolojik özellikleri ve risk faktörlerinin değerlendirilmesi. Mikrobiyol Bul 2011; 45: 489–503 (article in Turkish).
Durmaz B, Durmaz R, Otlu B, Sonmez E. Nosocomial infections in a new medical center, Turkey. Infect Control Hosp Epidemiol 2000; 21: 534–536.